While SARS-CoV-2 specific neutralizing antibodies have been developed for therapeutic
purposes, the specific viral triggers that drive the generation of SARS-CoV-2 specific IgG …

The interaction between the Spike (S) protein of SARS-CoV-2 and the human angiotensin
converting enzyme 2 (hACE2) is essential for infection, and is a target for neutralizing …

The ongoing enormous loss of human life owing to Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), has led to a global crisis ranging from the collapse of health …

The first direful biomolecular event leading to COVID-19 disease is the SARS-CoV-2 virus
surface spike (S) protein-mediated interaction with the human transmembrane protein …

Efficient COVID-19 vaccines are widely acknowledged as the best way to end the global
pandemic. SARS-CoV-2 receptor-binding domain (RBD) plays fundamental roles related to …

Metabolic diseases, like hypertension, excess weight, obesity, type 2 diabetes, and vascular
diseases, have rapidly increased to epidemic proportions worldwide. Metabolic risks (such …

Since the 2019 novel coronavirus outbreak began in Wuhan, China, diagnostic methods in
the field of molecular biology have been developing faster than ever under the vigilant eye …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) results in a variety of
clinical symptoms ranging from no or mild to severe disease. Currently, there are multiple …

The SARS-CoV-2 pandemic highlights the need for a detailed molecular understanding of
protective antibody responses. This is underscored by the emergence and spread of SARS …

As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest
in the longevity of immune protection, especially with regard to increasingly infectious virus …